Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group

The Children's Cancer Group (CCG) 1952 clinical trial for children with standard-risk acute lymphoblastic leukemia (SR-ALL) compared intrathecal (IT) methotrexate (MTX) with IT triples (ITT) (MTX, cytarabine, and hydrocortisone sodium succinate [HSS]) as presymptomatic central nervous system (C...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Matloub, Yousif, Lindemulder, Susan, Gaynon, Paul S., Sather, Harland, La, Mei, Broxson, Emmett, Yanofsky, Rochelle, Hutchinson, Raymond, Heerema, Nyla A., Nachman, James, Blake, Marilyn, Wells, Linda M., Sorrell, April D., Masterson, Margaret, Kelleher, John F., Stork, Linda C.
Formato: Artigo
Idioma:Inglês
Publicado em: The American Society of Hematology 2006
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1895867/
https://ncbi.nlm.nih.gov/pubmed/16609069
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2005-12-011809
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados